George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 411.00
Bid: 401.50
Ask: 410.00
Change: -23.00 (-5.30%)
Spread: 8.50 (2.117%)
Open: 429.00
High: 429.00
Low: 411.00
Prev. Close: 434.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of approximately 5% of AIB Group plc

7 Nov 2023 07:00

RNS Number : 5645S
Morgan Stanley & Co. Int'l plc
07 November 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SWITZERLAND OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT

 

7 November 2023

 

 

Disposal of approximately 5% of AIB Group plc

 

Further to his announcement on 6 November 2023, the Minister for Finance, Michael McGrath TD, announces the successful completion of the disposal of part of the Irish State's shareholding in AIB Group plc (the "Company"). The disposal was effected by way of a placing (the "Placing") of shares (the "Placing Shares") in an accelerated book building process to institutional investors.

 

In  summary, following settlement of the Placing which will take place on 9 November 2023:

 

? The shareholding of the Irish State will be reduced from 1,198.6 million ordinary shares, representing approximately 45.8% of the ordinary share capital of the Company, to 1,067.6 million ordinary shares, representing approximately 40.8 % of the ordinary share capital.

 

? Accordingly, the overall size of the State's shareholding will be reduced by approximately 5.0%.

 

? The Placing price was ?3.93 per share. As a result, the gross proceeds from the sale of the Placing Shares will be ? 514.83 million. Upon settlement, this sum will be returned to the Ireland Strategic Investment Fund pending further consideration by the Minister.

 

? BNP Paribas, Goldman Sachs and Morgan Stanley acted as Joint Bookrunners in connection with the Placing.

 

? The Minister for Finance has undertaken to the Joint Bookrunners not to sell further shares in the Company for the period of 90 calendar days following the completion of the Placing without the prior written consent of the Joint Bookrunners. While this undertaking also applies to any sales through the Minister's trading plan announced by way of Regulatory News Service on 21 December 2021, extended on 23 June 2022, 5 January 2023 and further extended on 27 June 2023, it will only do so for the period of 45 calendar days following the completion of the Placing.

 

? N.M. Rothschild & Sons Limited ("Rothschild & Co") is acting as independent financial adviser and William Fry LLP and Allen & Overy LLP are acting as legal counsel to the Department of Finance in connection with the sale.

 

Enquiries:

 

Brian Meenan, Press Officer, Department of Finance, +3531 6045875 or + 353 872198857

 

pressoffice@finance.gov.ie

Important Information

 

This announcement is for information purposes only and does not constitute an offer or an invitation to acquire or dispose of any securities of the Company in the United States, Canada, Australia or Japan or in any other jurisdiction in which such an offer of solicitation is unlawful. The shares sold pursuant to the Placing have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under any securities laws of any state or jurisdiction of the United States and may not be offered or sold in the United States absent registration or an exemption from registration. There was no public offering of securities in the United States.

 

Neither this announcement nor any copy of it may be taken, transmitted or distributed, directly

or indirectly in or into the United States of America, Australia, Canada, Japan, The Republic of South Africa, Switzerland or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. Any failure to comply with this restriction may constitute a violation of the securities laws of any such jurisdiction.

 

Goldman Sachs and Morgan Stanley which are authorised by the Prudential Regulation Authority (the "PRA") and regulated by the Financial Conduct Authority (the "FCA") and the PRA in the United Kingdom and BNP Paribas which is authorised and regulated by the European Central Bank and the Autorité de contrôle prudentiel et de resolution and authorised by the Prudential Regulation Authority and is subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority (together the "Joint Bookrunners"), and N.M. Rothschild & Sons Limited (the "Adviser") which is authorised and regulated by the FCA in the United Kingdom, are acting on behalf of the Minister for Finance and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of their respective clients or for providing advice to any other person in relation to any offering of the Placing Shares. None of the Joint Bookrunners nor the Adviser will regard any other person as its client in relation to the offering of the Placing Shares. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by any of the Joint Bookrunners, the Adviser or by any of their respective affiliates or agents as to or in relation to, the accuracy, completeness or sufficiency of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers in connection with the Minister for Finance, the Company, the Placing Shares, the Placing or any of the arrangements described herein, and any liability therefor is expressly disclaimed.

 

 

No Placing Shares will be available to any investor whose purchase of such Placing Shares, whether on its own account or as a fiduciary or agent for one or more investor accounts, would require regulatory consent in any jurisdiction (including, without limitation, under the UK Financial Services and Markets Act 2000 or the United States Bank Holding Company Act of 1956).

 

Details about the extent of BNP Paribas' regulation by the Prudential Regulation Authority are available from them on request.

 

BNP Paribas London Branch is registered in the UK under number FC13447. UK establishment number: BR000170. UK establishment office address: 10 Harewood Avenue, London NW1 6AA

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOELQLLBXFLZFBD
Date   Source Headline
26th Apr 202410:13 amRNSRE EGM: Final Price in respect of Buyback Contract
24th Apr 20249:32 amRNSStabilisation Notice
23rd Apr 20245:16 pmRNSHolding(s) in Company
23rd Apr 20249:23 amRNSStabilisation Notice
3rd Apr 20243:00 pmRNSNotice of GM
3rd Apr 20243:00 pmRNSNotice of AGM
25th Mar 20248:34 amRNSHolding(s) in Company
11th Mar 20249:51 amRNSDirector/PDMR Shareholding
6th Mar 20247:15 amRNSDividend Declaration
6th Mar 20247:00 amRNS2023 Annual Financial Results Announcement
4th Mar 20244:25 pmRNSHolding(s) in Company
27th Feb 20242:23 pmRNSHolding(s) in Company
16th Feb 20243:35 pmRNSHolding(s) in Company
30th Jan 202412:36 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSFurther Renewal of the AIB share trading plan
14th Dec 20233:37 pmRNSHolding(s) in Company
11th Dec 20233:40 pmRNSHolding(s) in Company
24th Nov 20235:31 pmRNSHolding(s) in Company
8th Nov 20235:17 pmRNSHolding(s) in Company
8th Nov 202311:43 amRNSHolding(s) in Company
7th Nov 20235:35 pmRNSHolding(s) in Company
7th Nov 20237:08 amRNSAIB Group plc - Statement on State Divestment
7th Nov 20237:00 amRNSDisposal of approximately 5% of AIB Group plc
6th Nov 202311:34 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSQ3 2023 Trading Statement
18th Oct 20239:58 amRNSStabilisation Notice
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20239:32 amRNSStabilisation Notice
11th Oct 20234:19 pmRNSHolding(s) in Company
21st Sep 20234:29 pmRNSHolding(s) in Company
1st Sep 20231:31 pmRNSHolding(s) in Company
21st Aug 20234:07 pmRNSHolding(s) in Company
28th Jul 20235:51 pmRNSEBA European-wide stress test 2023
28th Jul 20237:00 amRNSHalf-year Report 2023
13th Jul 20235:53 pmRNSHolding(s) in Company
11th Jul 202312:45 pmRNSHolding(s) in Company
30th Jun 20235:59 pmRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
28th Jun 20237:05 amRNSAIB Group plc - Statement on State Divestment
28th Jun 20237:00 amRNSResults of Secondary Placing in AIB Group plc
27th Jun 20235:09 pmRNSProposed Secondary Placing of Ordinary shares
23rd Jun 20233:27 pmRNSHolding(s) in Company
9th Jun 20233:56 pmRNSHolding(s) in Company
9th Jun 20237:00 amRNSHolding(s) in Company
1st Jun 20232:09 pmRNSHolding(s) in Company
12th May 20235:28 pmRNSHolding(s) in Company
12th May 20231:40 pmRNSDirector/PDMR Shareholding
4th May 20234:50 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.